Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) EBIT Margin (2020 - 2025)

NeuroPace has reported EBIT Margin over the past 6 years, most recently at 6.65% for Q4 2025.

  • Quarterly results put EBIT Margin at 6.65% for Q4 2025, up 1037.0% from a year ago — trailing twelve months through Dec 2025 was 16.34% (up 1078.0% YoY), and the annual figure for FY2025 was 16.34%, up 1078.0%.
  • EBIT Margin for Q4 2025 was 6.65% at NeuroPace, up from 9.51% in the prior quarter.
  • Over the last five years, EBIT Margin for NPCE hit a ceiling of 6.65% in Q4 2025 and a floor of 107.59% in Q2 2022.
  • Median EBIT Margin over the past 5 years was 36.34% (2023), compared with a mean of 46.19%.
  • Biggest five-year swings in EBIT Margin: crashed -7113bps in 2022 and later skyrocketed 6002bps in 2023.
  • NeuroPace's EBIT Margin stood at 81.98% in 2021, then rose by 6bps to 77.09% in 2022, then skyrocketed by 64bps to 28.04% in 2023, then skyrocketed by 39bps to 17.02% in 2024, then soared by 61bps to 6.65% in 2025.
  • The last three reported values for EBIT Margin were 6.65% (Q4 2025), 9.51% (Q3 2025), and 29.01% (Q2 2025) per Business Quant data.